x |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
¨ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| Delaware |
77-0073042 | |
| (State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification
No.) |
| 522 Almanor Avenue, Sunnyvale, CA |
94085 | |
| (Address of principal executive offices) |
(Zip Code) |
| Page | ||||
| Part I. Financial Information |
||||
| Item 1. |
1 | |||
| Item 2. |
17 | |||
| Item 3. |
50 | |||
| Item 4. |
51 | |||
| Part II. Other Information |
||||
| Item 1. |
51 | |||
| Item 2. |
52 | |||
| Item 3. |
52 | |||
| Item 4. |
52 | |||
| Item 5. |
52 | |||
| Item 6. |
53 | |||
| 53 | ||||
| 54 | ||||
| September 30, 2002 |
December 31, 2001 |
|||||||
| (unaudited) |
||||||||
| Assets |
||||||||
| Current assets: |
||||||||
| Cash and cash equivalents |
$ |
2,278 |
|
$ |
15,208 |
| ||
| Short-term investments |
|
18,032 |
|
|
27,118 |
| ||
| Accounts receivable, net |
|
1,831 |
|
|
1,158 |
| ||
| Inventories |
|
2,248 |
|
|
1,894 |
| ||
| Other current assets |
|
1,056 |
|
|
1,062 |
| ||
| |
|
|
|
|
| |||
| Total current assets |
|
25,445 |
|
|
46,440 |
| ||
| Property and equipment, net |
|
7,073 |
|
|
7,285 |
| ||
| Long-term investments |
|
16,593 |
|
|
9,058 |
| ||
| Investment in GCS |
|
7,500 |
|
|
|
| ||
| Intangible and other assets |
|
1,058 |
|
|
1,260 |
| ||
| Goodwill |
|
834 |
|
|
|
| ||
| |
|
|
|
|
| |||
| Total assets |
$ |
58,503 |
|
$ |
64,043 |
| ||
| |
|
|
|
|
| |||
| Liabilities and stockholders equity |
||||||||
| Current liabilities: |
||||||||
| Accounts payable |
$ |
2,009 |
|
$ |
1,464 |
| ||
| Accrued expenses |
|
2,184 |
|
|
1,745 |
| ||
| Deferred margin on distributor inventory |
|
2,035 |
|
|
3,631 |
| ||
| Accrued restructuring |
|
1,916 |
|
|
2,155 |
| ||
| Capital lease obligations, current portion |
|
593 |
|
|
634 |
| ||
| |
|
|
|
|
| |||
| Total current liabilities |
|
8,737 |
|
|
9,629 |
| ||
| Capital lease obligations and other long-term liabilities |
|
154 |
|
|
401 |
| ||
| Stockholders equity |
||||||||
| Common Stock |
|
30 |
|
|
30 |
| ||
| Additional paid-in capital |
|
128,862 |
|
|
128,426 |
| ||
| Deferred stock compensation |
|
(996 |
) |
|
(1,787 |
) | ||
| Accumulated deficit |
|
(78,119 |
) |
|
(72,656 |
) | ||
| Treasury stock, at cost |
|
(165 |
) |
|
|
| ||
| |
|
|
|
|
| |||
| Total stockholders equity |
|
49,612 |
|
|
54,013 |
| ||
| |
|
|
|
|
| |||
| Total liabilities and stockholders equity |
$ |
58,503 |
|
$ |
64,043 |
| ||
| |
|
|
|
|
| |||
| Three Months Ended |
Nine Months Ended |
|||||||||||||||
| September 30, 2002 |
September 30, 2001 |
September 30, 2002 |
September 30, 2001 |
|||||||||||||
| Net revenues |
$ |
5,206 |
|
$ |
3,188 |
|
$ |
14,939 |
|
$ |
16,343 |
| ||||
| Cost of revenues (exclusive of amortization of deferred stock compensation of $48, $110, $32 and $106 for the three and
nine months ended September 30, 2002 and three and nine months ended September 30, 2001, respectively) |
|
2,401 |
|
|
7,468 |
|
|
6,022 |
|
|
15,084 |
| ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Gross profit (loss) |
|
2,805 |
|
|
(4,280 |
) |
|
8,917 |
|
|
1,259 |
| ||||
| Operating expenses: |
||||||||||||||||
| Research and development (exclusive of amortization of deferred stock compensation of $65, $161, $61 and $204 for the
three and nine months ended September 30, 2002 and three and nine months ended September 30, 2001, respectively) |
|
1,889 |
|
|
3,116 |
|
|
4,945 |
|
|
7,619 |
| ||||
| Sales and marketing (exclusive of amortization of deferred stock compensation of $75, $195, $65 and $216 for the three
and nine months ended September 30, 2002 and three and nine months ended September 30, 2001, respectively) |
|
1,244 |
|
|
1,365 |
|
|
3,675 |
|
|
4,419 |
| ||||
| General and administrative (exclusive of amortization of deferred stock compensation of $125, $325, $314 and $621 for
the three and nine months ended September 30, 2002 and three and nine months ended September 30, 2001, respectively) |
|
1,241 |
|
|
1,111 |
|
|
3,622 |
|
|
3,340 |
| ||||
| Amortization of deferred stock compensation |
|
313 |
|
|
472 |
|
|
791 |
|
|
1,147 |
| ||||
| In-process research and development |
|
2,200 |
|
|
|
|
|
2,200 |
|
|
|
| ||||
| Restructuring |
|
(112 |
) |
|
|
|
|
(112 |
) |
|
|
| ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Total operating expenses |
|
6,775 |
|
|
6,064 |
|
|
15,121 |
|
|
16,525 |
| ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Loss from operations |
|
(3,970 |
) |
|
(10,344 |
) |
|
(6,204 |
) |
|
(15,266 |
) | ||||
| Interest expense |
|
13 |
|
|
26 |
|
|
48 |
|
|
99 |
| ||||
| Interest income and other, net |
|
245 |
|
|
1,086 |
|
|
789 |
|
|
3,153 |
| ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Loss before taxes |
|
(3,738 |
) |
|
(9,284 |
) |
|
(5,463 |
) |
|
(12,212 |
) | ||||
| Provision for income taxes |
|
|
|
|
3,154 |
|
|
|
|
|
2,276 |
| ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Net loss |
$ |
(3,738 |
) |
$ |
(12,438 |
) |
$ |
(5,463 |
) |
$ |
(14,488 |
) | ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Net loss per share |
||||||||||||||||
| Basic |
$ |
(0.13 |
) |
$ |
(0.42 |
) |
$ |
(0.18 |
) |
$ |
(0.50 |
) | ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Diluted |
$ |
(0.13 |
) |
$ |
(0.42 |
) |
$ |
(0.18 |
) |
$ |
(0.50 |
) | ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Shares used to compute net loss per share |
||||||||||||||||
| Basic |
|
29,869 |
|
|
29,447 |
|
|
29,837 |
|
|
28,996 |
| ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Diluted |
|
29,869 |
|
|
29,447 |
|
|
29,837 |
|
|
28,996 |
| ||||
| |
|
|
|
|
|
|
|
|
|
|
| |||||
| Nine Months Ended |
||||||||
| September 30, 2002 |
September 30, 2001 |
|||||||
| Operating Activities |
||||||||
| Net loss |
$ |
(5,463 |
) |
$ |
(14,488 |
) | ||
| Adjustments to reconcile net loss to net cash used in operating activities: |
||||||||
| Depreciation and amortization |
|
2,136 |
|
|
2,091 |
| ||
| Deferred tax assets |
|
|
|
|
2,277 |
| ||
| Retirement of property and equipment |
|
56 |
|
|
|
| ||
| Abandoned and impaired equipment |
|
|
|
|
1,468 |
| ||
| Amortization of deferred stock compensation |
|
791 |
|
|
1,147 |
| ||
| In-process research and development |
|
2,200 |
|
|
|
| ||
| Changes in operating assets and liabilities: |
||||||||
| Accounts receivable |
|
(519 |
) |
|
2,500 |
| ||
| Inventories |
|
(208 |
) |
|
5,039 |
| ||
| Other assets |
|
(138 |
) |
|
572 |
| ||
| Accounts payable |
|
348 |
|
|
(495 |
) | ||
| Accrued expenses |
|
56 |
|
| ||||